ALLOCYTE Trademark

Trademark Overview


On Monday, July 19, 2021, a trademark application was filed for ALLOCYTE with the United States Patent and Trademark Office. The USPTO has given the ALLOCYTE trademark a serial number of 90836264. The federal status of this trademark filing is REGISTERED as of Tuesday, March 14, 2023. This trademark is owned by SCENDIA BIOLOGICS, LLC. The ALLOCYTE trademark is filed in the Pharmaceutical Products category with the following description:

Allograft based biologics products, namely, an advanced cellular bone matrix for promoting bone formation, excluding wound healing and/or stem cell products
allocyte

General Information


Serial Number90836264
Word MarkALLOCYTE
Filing DateMonday, July 19, 2021
Status700 - REGISTERED
Status DateTuesday, March 14, 2023
Registration Number7001736
Registration DateTuesday, March 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Goods and ServicesAllograft based biologics products, namely, an advanced cellular bone matrix for promoting bone formation, excluding wound healing and/or stem cell products
Pseudo MarkALLOCATE; ALL OCYTE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 21, 2021
Primary Code005
First Use Anywhere DateThursday, September 15, 2022
First Use In Commerce DateThursday, September 15, 2022

Trademark Owner History


Party NameSANARA MEDTECH, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFORT WORTH, TX 76102

Party NameSCENDIA BIOLOGICS, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressOrlando, FL 32801

Party NameSCENDIA BIOLOGICS, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOrlando, FL 32801

Party NameSCENDIA BIOLOGICS, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOrlando, FL 32801

Trademark Events


Event DateEvent Description
Wednesday, February 28, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 14, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, February 9, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 8, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 8, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 10, 2023USE AMENDMENT FILED
Wednesday, February 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 10, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, January 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 11, 2022NON-FINAL ACTION E-MAILED
Monday, April 11, 2022NON-FINAL ACTION WRITTEN
Monday, April 11, 2022ASSIGNED TO EXAMINER
Tuesday, September 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 22, 2021NEW APPLICATION ENTERED